1
|
Xu Z, Wang Z, Shi X, Ding R, Han L, Yang X, Zhang H, Hobson AD. Impact of atropisomerism on a non-steroidal glucocorticoid receptor agonist. RSC Med Chem 2024; 15:2357-2371. [PMID: 39026657 PMCID: PMC11253871 DOI: 10.1039/d4md00245h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2024] [Accepted: 05/30/2024] [Indexed: 07/20/2024] Open
Abstract
To investigate atropisomers of non-steroidal glucocorticoid receptor modulator GSK866, a virtual library of substituted benzoic acid analogues was enumerated. Compounds from this library were subjected to a torsion angle scan using Spartan'20 to calculate the torsion rotation energy barrier which identified compounds predicted to be stable as atropisomers. After synthesis of the library, analysis showed that compounds 13 and 14 existed as stable atropisomers 13a, 13b, 14a and 14b, in agreement with the earlier calculations. Screening in a glucocorticoid receptor cellular assay showed that one compound from each atropisomer pair was significantly more potent than the other. Docking in a public structure of the glucocorticoid receptor (PBD code 3E7C) enabled the stereochemistry of the two most potent compounds 13a and 14b to be assigned as (R a) and (S a), respectively.
Collapse
Affiliation(s)
- Zhou Xu
- WuXi AppTec, Tianjin Economic-Technological Development Area TEDA 168 Nanhai Road, TJS 300457 China
| | - Zhongyuan Wang
- WuXi AppTec, Tianjin Economic-Technological Development Area TEDA 168 Nanhai Road, TJS 300457 China
| | - Xiaona Shi
- WuXi AppTec, Tianjin Economic-Technological Development Area TEDA 168 Nanhai Road, TJS 300457 China
| | - Rui Ding
- WuXi AppTec, Tianjin Economic-Technological Development Area TEDA 168 Nanhai Road, TJS 300457 China
| | - Li Han
- WuXi AppTec, Waigaoqiao Free Trade Zone 288 Fute Zhong Road, Pudong New Area Shanghai 200131 China
| | - Xueping Yang
- WuXi AppTec, Waigaoqiao Free Trade Zone 288 Fute Zhong Road, Pudong New Area Shanghai 200131 China
| | - Hongmei Zhang
- WuXi AppTec, Waigaoqiao Free Trade Zone 288 Fute Zhong Road, Pudong New Area Shanghai 200131 China
| | - Adrian D Hobson
- AbbVie Bioresearch Center 381 Plantation Street Worcester Massachusetts 01605 USA
| |
Collapse
|
2
|
Martínez-Pardo P, Blay G, Vila C, Sanz-Marco A, Muñoz MC, Pedro JR. Enantioselective Synthesis of 5-Trifluoromethyl-2-oxazolines under Dual Silver/Organocatalysis. J Org Chem 2018; 84:314-325. [DOI: 10.1021/acs.joc.8b02808] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Pablo Martínez-Pardo
- Departament de Química Orgànica, Facultat de Química, Universitat de València, Burjassot, València 46100, Spain
| | - Gonzalo Blay
- Departament de Química Orgànica, Facultat de Química, Universitat de València, Burjassot, València 46100, Spain
| | - Carlos Vila
- Departament de Química Orgànica, Facultat de Química, Universitat de València, Burjassot, València 46100, Spain
| | - Amparo Sanz-Marco
- Departament de Química Orgànica, Facultat de Química, Universitat de València, Burjassot, València 46100, Spain
| | - M. Carmen Muñoz
- Departament de Física Aplicada, Universitat Politècnica de València, València 46022, Spain
| | - José R. Pedro
- Departament de Química Orgànica, Facultat de Química, Universitat de València, Burjassot, València 46100, Spain
| |
Collapse
|
3
|
Ryabtsova O, Joossens J, Van Der Veken P, Vanden Berghe W, Augustyns K, De Winter H. Novel selective glucocorticoid receptor agonists (SEGRAs) with a covalent warhead for long-lasting inhibition. Bioorg Med Chem Lett 2016; 26:5032-5038. [DOI: 10.1016/j.bmcl.2016.08.091] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2016] [Revised: 08/26/2016] [Accepted: 08/29/2016] [Indexed: 11/16/2022]
|
4
|
Abstract
Although several methods have been used in bone regeneration medicine, current methods still have many limitations. The tissue used for autogenous bone graft is limited and allograft has weak osteoinductive activity. Tissue engineering provides a good choice for bone regeneration. However, the growth factors needed have a high price and short half-life. Recently, a number of small molecules have been confirmed to have osteoinductive activity and some have been clinically used. Natural small molecules including decalpenic acid, flavonoids, quinones can be extracted from plants and others can be synthesized according to the structure designed or mimicking the structure of natural small molecules. Small molecules can act as co-activator of BMP2 pathway or activate Wnt pathway; others can be the inhibitors of NF-κB signaling pathway. This review gives an overview on the small molecules with osteoinductive activity and discusses the mechanism of the small molecules.
Collapse
|
5
|
Kuzmich D, Bentzien J, Betageri R, DiSalvo D, Fadra-Khan T, Harcken C, Kukulka A, Nabozny G, Nelson R, Pack E, Souza D, Thomson D. Function-regulating pharmacophores in a sulfonamide class of glucocorticoid receptor agonists. Bioorg Med Chem Lett 2013; 23:6640-4. [DOI: 10.1016/j.bmcl.2013.10.052] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2013] [Revised: 10/22/2013] [Accepted: 10/23/2013] [Indexed: 11/16/2022]
|
6
|
Abstract
AIMS To investigate the effect of 1-(4-(tert-butyl)benzyl)-N-(4-methoxyphenyl)-3-phenyl-1H-pyrazole-5-carboxamide (Pyr-C) on the proliferation and osteogenic differentiation of MC3T3-E1 cells. MATERIALS & METHODS MTT and BrdU incorporation assay were used to determine cell survival and proliferation. The gene expression levels of osteogenic markers were determined using real-time PCR and ALP activity was detected. Western-blot analysis was used to determine the protein expression of BSP and OPN. The long-term effect of Pyr-C on mineralization deposition was measured by Alizarin Red Staining. RESULTS Pyr-C inhibited cell proliferation and increased ALP activity. Gene expression of ALP, BSP, OCN, Runx2, and Osterix was up-regulated in Pyr-C-induced group. Pyr-C increased the protein expression of BSP at day 7, 14 and 21, and OPN at day 14, 21 and 28. Meanwhile, Pyr-C enhanced the mineral deposition. CONCLUSION Pyr-C inhibits proliferation and stimulates osteogenic differentiation of MC3T3-E1 cells.
Collapse
|
7
|
Lv HS, Han QQ, Ding XL, Zhou JL, Yang PS, Miao JY, Zhao BX. Synthesis and Discovery of Novel Pyrazole Carboxamide Derivatives as Potential Osteogenesis Inducers. Arch Pharm (Weinheim) 2012; 345:870-7. [DOI: 10.1002/ardp.201200180] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2012] [Revised: 06/20/2012] [Accepted: 06/27/2012] [Indexed: 11/06/2022]
|
8
|
RAZAVI HOSSEIN, HARCKEN CHRISTIAN. Non-steroidal Dissociated Glucocorticoid Receptor Agonists. ANTI-INFLAMMATORY DRUG DISCOVERY 2012. [DOI: 10.1039/9781849735346-00481] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Synthetic glucocorticoids, such as dexamethasone and prednisolone, are amongst the most commonly used drugs due to their potent and efficacious anti-inflammatory and immunosuppressive properties. However, their long-term and/or high-dose administration is limited by a number of deleterious side-effects, including glucocorticoid-induced diabetes and osteoporosis. Glucocorticoids exert their effects through binding to the glucocorticoid receptor. Since the discovery of multiple differentiated down-stream functions of the glucocorticoid-bound receptor, such as gene transrepression and transactivation, researchers in academia and industry have been on a quest to discover novel glucocorticoids that achieve functional selectivity, hence dissociating the desired anti-inflammatory from the undesired side-effects. This review describes the current state of discovery and development of non-steroidal glucocorticoid receptor agonists. Several small-molecule drug candidates have advanced into clinical trials, and have shown promising early biomarker data, as well as beneficial effects in topical applications. However, a clinically efficacious and systemically available glucocorticoid with significantly reduced side-effects as compared to current steroidal drugs, the “Holy Grail” in immunology, is still elusive.
Collapse
Affiliation(s)
- HOSSEIN RAZAVI
- Department of Medicinal Chemistry Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877 USA
| | - CHRISTIAN HARCKEN
- Department of Research Networking & Strategic Planning Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877 USA
| |
Collapse
|
9
|
Discovery of selective glucocorticoid receptor modulator MK-5932. Bioorg Med Chem 2011; 19:7374-86. [DOI: 10.1016/j.bmc.2011.10.054] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2011] [Revised: 10/10/2011] [Accepted: 10/18/2011] [Indexed: 11/22/2022]
|
10
|
Tetrahydroquinolin-3-yl carbamate glucocorticoid receptor agonists with reduced PEPCK activation. Bioorg Med Chem Lett 2011; 21:1658-62. [DOI: 10.1016/j.bmcl.2011.01.106] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2010] [Accepted: 01/24/2011] [Indexed: 01/22/2023]
|
11
|
Diallo H, Angell DC, Barnett HA, Biggadike K, Coe DM, Cooper TW, Craven A, Gray JR, House D, Jack TI, Keeling SP, Macdonald SJ, McLay IM, Oliver S, Taylor SJ, Uings IJ, Wellaway N. Discovery of a potent series of non-steroidal non α-trifluoromethyl carbinol glucocorticoid receptor agonists with reduced lipophilicity. Bioorg Med Chem Lett 2011; 21:1126-33. [DOI: 10.1016/j.bmcl.2010.12.121] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2010] [Revised: 12/22/2010] [Accepted: 12/23/2010] [Indexed: 01/29/2023]
|
12
|
Tetrahydroquinoline glucocorticoid receptor agonists: Discovery of a 3-hydroxyl for improving receptor selectivity. Bioorg Med Chem Lett 2011; 21:168-71. [DOI: 10.1016/j.bmcl.2010.11.047] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2010] [Revised: 11/04/2010] [Accepted: 11/08/2010] [Indexed: 11/24/2022]
|
13
|
Discovery of quinolines as selective glucocorticoid receptor agonists. Bioorg Med Chem Lett 2010; 20:5835-8. [DOI: 10.1016/j.bmcl.2010.07.125] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2009] [Revised: 07/27/2010] [Accepted: 07/28/2010] [Indexed: 11/19/2022]
|
14
|
Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor. Proc Natl Acad Sci U S A 2009; 106:18114-9. [PMID: 19822747 DOI: 10.1073/pnas.0909125106] [Citation(s) in RCA: 56] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Crystallography and computer modeling have been used to exploit a previously unexplored channel in the glucocorticoid receptor (GR). Highly potent, nonsteroidal indazole amides showing excellent complementarity to the channel were designed with the assistance of the computational technique AlleGrow. The accuracy of the design process was demonstrated through crystallographic structural determination of the GR ligand-binding domain-agonist complex of the D-prolinamide derivative 11. The utility of the channel was further exemplified through the design of a potent phenylindazole in which structural motifs, seen to interact with the traditional GR ligand pocket, were abandoned and replaced by interactions within the new channel. Occupation of the channel was confirmed with a second GR crystal structure of this truncated D-alaninamide derivative 13. Compound 11 displays properties compatible with development as an intranasal solution formulation, whereas oral bioavailability has been demonstrated with a related truncated exemplar 14. Data with the pyrrolidinone amide 12 demonstrate the potential for further elaboration within the "meta" channel to deliver compounds with selectivity for the desired transrepressive activity of glucocorticoids. The discovery of these interactions with this important receptor offers significant opportunities for the design of novel GR modulators.
Collapse
|
15
|
Synthesis of novel pyrazole carboxamide derivatives and discovery of modulators for apoptosis or autophagy in A549 lung cancer cells. Bioorg Med Chem Lett 2009; 19:5325-8. [DOI: 10.1016/j.bmcl.2009.07.131] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2009] [Revised: 07/25/2009] [Accepted: 07/29/2009] [Indexed: 01/07/2023]
|
16
|
Biggadike K, Caivano M, Clackers M, Coe DM, Hardy GW, Humphreys D, Jones HT, House D, Miles-Williams A, Skone PA, Uings I, Weller V, McLay IM, Macdonald SJ. Highly tractable, sub-nanomolar non-steroidal glucocorticoid receptor agonists. Bioorg Med Chem Lett 2009; 19:4846-50. [DOI: 10.1016/j.bmcl.2009.06.020] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2009] [Revised: 06/03/2009] [Accepted: 06/05/2009] [Indexed: 11/15/2022]
|